Vitenskapelig artikkel

• Sayadi, Ahmed; Sandling, Johanna K.; Eloranta, Maija Leena et al. (2025). Rare and common single nucleotide variants in childhood-onset systemic lupus erythematosus. (ekstern lenke)
• Álvez, María Bueno; Bergström, Sofia; Kenrick, Josefin et al. (2025). A human pan-disease blood atlas of the circulating proteome. (ekstern lenke)
• Björk, Albin; Mofors, Johannes; Meneghel, Lauro et al. (2025). A proteomic profile correlates with salivary gland inflammation and disease-associated antibodies in Sjögren’s disease. (ekstern lenke)
• Mofors, Johannes; Rudolph, André; Schiller, Bodil et al. (2025). Associations of infection burden with Kawasaki disease in a population-based setting during 30 years. (ekstern lenke)
• Wiley, Mandi M.; Radziszewski, Marcin; Khatri, Bhuwan et al. (2025). Variants in the DDX6-CXCR5 autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland. (ekstern lenke)
• Galindo-Feria, Angeles S.; Lodin, Karin; Horuluoglu, Begum et al. (2025). Anti-FHL1 autoantibodies in adult patients with myositis: a longitudinal follow-up analysis. (ekstern lenke)
• Sonesson, Sven-Erik; Ambrosi, Aurelie; Nordenstam, Felicia et al. (2024). Impact of early detection and steroid treatment on fetal ventricular heart rate and pacemaker implantation in anti-Ro/SSA positive congenital heart block. (ekstern lenke)
• Fugmann, Cecilia; Reid, Sarah; Pucholt, Pascal et al. (2024). A high polygenic risk score is associated with SSA/SSB antibody positivity and early onset in primary Sjögren’s disease. (ekstern lenke)
• Bianchi, Matteo; Kozyrev, Sergey V.; Notarnicola, Antonella et al. (2024). Unraveling the Genetics of Shared Clinical and Serological Manifestations in Patients With Systemic Inflammatory Autoimmune Diseases. (ekstern lenke)
• Rodríguez-Carrio, Javier; Burska, Agata; Conaghan, Philip G et al. (2023). 2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice. (ekstern lenke)
• Burska, Agata; Rodríguez-Carrio, Javier; Biesen, Robert et al. (2023). Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. (ekstern lenke)
• Rodríguez-Carrio, Javier; Burska, Agata; Conaghan, P.G. et al. (2023). Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. (ekstern lenke)
• Preger, Charlotta; Notarnicola, Antonella; Hellström, Cecilia et al. (2023). Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies. (ekstern lenke)
• Leclair, Valérie; Galindo-Feria, Angeles S.; Rothwell, Simon et al. (2023). Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathies. (ekstern lenke)
• Scheffschick, Andrea; Nenonen, Julia; Xiang, Mengmeng et al. (2023). Skin infiltrating NK cells in cutaneous T-cell lymphoma are increased in number and display phenotypic alterations partially driven by the tumor. (ekstern lenke)
• Lundtoft, Christian; Sjöwall, Christopher; Rantapää-Dahlqvist, Solbritt et al. (2022). Strong association of combined genetic deficiencies in the classical complement pathway with risk of systemic lupus erythematosus and primary Sjögren's syndrome. (ekstern lenke)
• Lundtoft, Christian; Pucholt, Pascal; Martin, Myriam et al. (2022). Complement C4 Copy Number Variation is Linked to SSA/Ro and SSB/La Autoantibodies in Systemic Inflammatory Autoimmune Diseases. (ekstern lenke)
• Meisgen, Sabrina; Hedlund, Malin; Ambrosi, Aurelie et al. (2022). Auxilin is a novel susceptibility gene for congenital heart block which directly impacts fetal heart function. (ekstern lenke)
• Khatri, Bhuwan; Tessneer, Kandice L.; Rasmussen, Astrid et al. (2022). Genome-wide association study identifies Sjögren’s risk loci with functional implications in immune and glandular cells. (ekstern lenke)
• Ivanchenko, M.; Thorlacius, Gudny Ella; Hedlund, Malin et al. (2021). Natural killer cells and type II interferon in Ro/SSA and La/SSB autoantibody-exposed newborns at risk of congenital heart block. (ekstern lenke)
• Ambrosi, Aurelie; Thorlacius, Gudny Ella; Sonesson, Sven-Erik et al. (2021). Interferons and innate immune activation in autoimmune congenital heart block. (ekstern lenke)
• Björk, Albin; Rodrigues, Rui Da Silva; Andersson, Elina Richardsdotter et al. (2021). Interferon activation status underlies higher antibody response to viral antigens in patients with systemic lupus erythematosus receiving no or light treatment. (ekstern lenke)
• Gao, Yu; Liu, Ruining; He, Chenfei et al. (2021). SOCS3 Expression by Thymic Stromal Cells Is Required for Normal T Cell Development. (ekstern lenke)
• Mofors, Johannes; Björk, Albin; Andersson, Elina Richardsdotter et al. (2020). Cigarette smoking patterns preceding primary Sjögren's syndrome. (ekstern lenke)

Vitenskapelig oversiktsartikkel/review

• Ramos-Casals, Manuel; Baer, Alan N.; Brito-Zerón, María del Pilar et al. (2025). 2023 International Rome consensus for the nomenclature of Sjögren disease. (ekstern lenke)
• Thorlacius, Gudny Ella; Björk, Albin; Herlenius, Marie Elisabeth Wahren (2023). Genetics and epigenetics of primary Sjögren syndrome: implications for future therapies. (ekstern lenke)

Errata

• Khatri, Bhuwan; Tessneer, Kandice L.; Rasmussen, Astrid et al. (2023). Author Correction: Genome-wide association study identifies Sjögren’s risk loci with functional implications in immune and glandular cells (Nature Communications, (2022), 13, 1, (4287), 10.1038/s41467-022-30773-y). (ekstern lenke)
• Khatri, Bhuwan; Tessneer, Kandice L.; Rasmussen, Astrid et al. (2022). Erratum: Author Correction: Genome-wide association study identifies Sjögren's risk loci with functional implications in immune and glandular cells (Nature communications (2022) 13 1 (4287)). (ekstern lenke)

Fagartikkel

• Seror, Raphaèle; Baron, Gabriel; Camus, Marine et al. (2022). Development and preliminary validation of the Sjögren's Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren's syndrome. (ekstern lenke)

Se en full oversikt over publikasjoner i Cristin